weight loss response to semaglutide in postmenopausal women this study, who were taking HRT with lost 30% more than women who were not on HRT. #menopause #weightloss #perimenopause #pauselife #womenover40 #womenshealth Should postmenopausal women use injectable

It was a pre-approval cardiac safety assessment trial with a primary objective of non-inferiority to placebo, which was basically done to get early approval as per regulatory guidance

The adjustment period is typically 4 to 8 weeks as your body gets used to the medication

Because of Novo Nordisks patents, generic semaglutide products will not be able to enter the U.S

Semaglutide GLP-1 is a GLP-1 agonist, known as a Glucagon-Like Peptide-1, which works on receptors in the brain as well as the pancreas to cause a decrease in appetite along with slowing of the digestion process which leads to feeling full longer

Provide written instructions summarising the plan

Time it carefully